会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Selective killing and diagnosis of p53+ neoplastic cells
    • 选择性杀伤和诊断p53 +肿瘤细胞
    • US06296845B1
    • 2001-10-02
    • US09190930
    • 1998-11-12
    • Adam Sampson-JohannesDavid Kirn
    • Adam Sampson-JohannesDavid Kirn
    • A61K4800
    • G01N33/57484A61K35/761C12N2710/10332C12N2710/10362
    • Methods and compositions for treating and diagnosing neoplastic disease using viruses are provided. Preferably, mutant adenovirus lacking viral proteins which bind and/or inactivate p53 are administered to a patient having a neoplasm which comprises cells exhibiting p53 and lacking, or substantially devoid of mismatch repair activity. The mutant virus is able to substantially produce a replication phenotype in such neoplastic cells but is substantially unable to produce a replication phenotype in non-replicating, non-neoplastic cells having essentially normal p53 function. The preferential generation of a replication phenotype in neoplastic cells results in a preferential killing of the neoplastic cells, either directly or by expression of a cytotoxic gene in cells expressing a viral replication phenotype.
    • 提供了使用病毒治疗和诊断肿瘤疾病的方法和组合物。 优选地,将具有结合和/或失活p53的病毒蛋白质的突变型腺病毒施用于具有肿瘤的患者,所述肿瘤包含表现出p53并且缺乏或基本上没有错配修复活性的细胞。 突变型病毒能够在这种肿瘤细胞中基本上产生复制表型,但是在具有基本正常p53功能的非复制型非肿瘤细胞中基本上不能产生复制表型。 在肿瘤细胞中优先产生复制表型导致直接或通过在表达病毒复制表型的细胞中表达细胞毒性基因来赘瘤细胞的优先杀伤。